BR0012675A - Uso de inibidores de il-18 - Google Patents

Uso de inibidores de il-18

Info

Publication number
BR0012675A
BR0012675A BR0012675-6A BR0012675A BR0012675A BR 0012675 A BR0012675 A BR 0012675A BR 0012675 A BR0012675 A BR 0012675A BR 0012675 A BR0012675 A BR 0012675A
Authority
BR
Brazil
Prior art keywords
inhibitors
tumor metastasis
metastasis
tumor
Prior art date
Application number
BR0012675-6A
Other languages
English (en)
Portuguese (pt)
Other versions
BRPI0012675B8 (US07585860-20090908-C00154.png
BRPI0012675B1 (pt
Inventor
Charles Dinarello
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of BRPI0012675B1 publication Critical patent/BRPI0012675B1/pt
Publication of BR0012675A publication Critical patent/BR0012675A/pt
Publication of BRPI0012675B8 publication Critical patent/BRPI0012675B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR0012675-6A 1999-07-22 2000-07-17 Uso de inibidores de il-18 BR0012675A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL131047 1999-07-22
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
PCT/IL2000/000419 WO2001007480A2 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (3)

Publication Number Publication Date
BRPI0012675B1 BRPI0012675B1 (pt) 2001-02-01
BR0012675A true BR0012675A (pt) 2002-04-09
BRPI0012675B8 BRPI0012675B8 (US07585860-20090908-C00154.png) 2021-05-25

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012675-6A BR0012675A (pt) 1999-07-22 2000-07-17 Uso de inibidores de il-18

Country Status (31)

Country Link
US (1) US7741276B2 (US07585860-20090908-C00154.png)
EP (1) EP1206274B1 (US07585860-20090908-C00154.png)
JP (1) JP4827352B2 (US07585860-20090908-C00154.png)
KR (1) KR100682219B1 (US07585860-20090908-C00154.png)
CN (1) CN1173736C (US07585860-20090908-C00154.png)
AR (1) AR024907A1 (US07585860-20090908-C00154.png)
AT (1) ATE363288T1 (US07585860-20090908-C00154.png)
AU (1) AU782478B2 (US07585860-20090908-C00154.png)
BG (1) BG65800B1 (US07585860-20090908-C00154.png)
BR (1) BR0012675A (US07585860-20090908-C00154.png)
CA (1) CA2380216C (US07585860-20090908-C00154.png)
CY (1) CY1107932T1 (US07585860-20090908-C00154.png)
CZ (1) CZ302114B6 (US07585860-20090908-C00154.png)
DE (2) DE1206274T1 (US07585860-20090908-C00154.png)
DK (1) DK1206274T3 (US07585860-20090908-C00154.png)
EA (1) EA005419B1 (US07585860-20090908-C00154.png)
EE (1) EE04838B1 (US07585860-20090908-C00154.png)
ES (1) ES2186596T3 (US07585860-20090908-C00154.png)
HK (1) HK1048248B (US07585860-20090908-C00154.png)
HU (1) HU228780B1 (US07585860-20090908-C00154.png)
IL (2) IL131047A0 (US07585860-20090908-C00154.png)
MX (1) MXPA02000838A (US07585860-20090908-C00154.png)
NO (1) NO329827B1 (US07585860-20090908-C00154.png)
NZ (1) NZ516535A (US07585860-20090908-C00154.png)
PL (1) PL202477B1 (US07585860-20090908-C00154.png)
PT (1) PT1206274E (US07585860-20090908-C00154.png)
SK (1) SK287522B6 (US07585860-20090908-C00154.png)
TR (1) TR200200169T2 (US07585860-20090908-C00154.png)
UA (1) UA73745C2 (US07585860-20090908-C00154.png)
WO (1) WO2001007480A2 (US07585860-20090908-C00154.png)
ZA (1) ZA200200390B (US07585860-20090908-C00154.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101111103B1 (ko) * 2000-02-10 2012-02-13 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법
JP2004528010A (ja) 2000-10-11 2004-09-16 バイロン・セラピューティックス・インコーポレーテッド 免疫モジュレーションのための核酸およびポリペプチド
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
EA008667B1 (ru) * 2002-10-08 2007-06-29 Арес Трейдинг С.А. Применение цитокина, способного связывать il-18bp и ингибировать активность второго цитокина
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
ES2370417T3 (es) 2005-06-03 2011-12-15 Ares Trading S.A. Producción de una proteína de unión a il-18 recombinante.
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
WO2023178192A1 (en) 2022-03-15 2023-09-21 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332668T2 (de) * 1992-09-02 2003-12-18 Isis Pharmaceutical Inc Beeinflussing der zelladhäsie durch oligonukleotide
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
CA2282845A1 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
NO20020153D0 (no) 2002-01-11
DE60035049D1 (de) 2007-07-12
ES2186596T1 (es) 2003-05-16
PL202477B1 (pl) 2009-06-30
KR100682219B1 (ko) 2007-02-12
NO20020153L (no) 2002-03-11
HK1048248B (zh) 2005-04-22
HUP0202107A2 (en) 2002-10-28
HU228780B1 (en) 2013-05-28
BRPI0012675B8 (US07585860-20090908-C00154.png) 2021-05-25
SK882002A3 (en) 2002-07-02
ATE363288T1 (de) 2007-06-15
IL131047A0 (en) 2001-01-28
AR024907A1 (es) 2002-10-30
AU782478B2 (en) 2005-08-04
SK287522B6 (sk) 2011-01-04
MXPA02000838A (es) 2002-07-30
EP1206274B1 (en) 2007-05-30
DK1206274T3 (da) 2007-08-13
EA200200189A1 (ru) 2002-12-26
EA005419B1 (ru) 2005-02-24
CZ2002195A3 (cs) 2002-06-12
DE1206274T1 (de) 2002-11-14
CA2380216C (en) 2012-01-31
WO2001007480A3 (en) 2001-05-10
PT1206274E (pt) 2007-07-06
WO2001007480A2 (en) 2001-02-01
BG106311A (en) 2002-08-30
JP4827352B2 (ja) 2011-11-30
IL147675A (en) 2009-05-04
US20080003216A1 (en) 2008-01-03
NZ516535A (en) 2004-04-30
CA2380216A1 (en) 2001-02-01
DE60035049T2 (de) 2007-09-27
ZA200200390B (en) 2003-04-30
CN1173736C (zh) 2004-11-03
BRPI0012675B1 (pt) 2001-02-01
HUP0202107A3 (en) 2005-01-28
NO329827B1 (no) 2011-01-03
UA73745C2 (en) 2005-09-15
HK1048248A1 (en) 2003-03-28
EE200200032A (et) 2003-02-17
BG65800B1 (bg) 2009-12-31
CY1107932T1 (el) 2013-09-04
CZ302114B6 (cs) 2010-10-20
CN1364086A (zh) 2002-08-14
EE04838B1 (et) 2007-06-15
KR20020027493A (ko) 2002-04-13
PL353732A1 (en) 2003-12-01
AU5843200A (en) 2001-02-13
ES2186596T3 (es) 2007-11-16
JP2003505472A (ja) 2003-02-12
US7741276B2 (en) 2010-06-22
EP1206274A2 (en) 2002-05-22
TR200200169T2 (tr) 2002-06-21

Similar Documents

Publication Publication Date Title
DE69907977D1 (de) Pyrrolobenzodiazepine
BR9912327A (pt) Inibidores da uroquinase
MY129409A (en) Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
UY27972A1 (es) Derivados de hidantoína
DE60136181D1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
DE60216233D1 (en) Carbolinderivate
BRPI0208558A2 (pt) preparado de combinação de estrogênio-gestagênio e uso
BR0012675A (pt) Uso de inibidores de il-18
PT1242410E (pt) Compostos novos
FR2816843B1 (fr) Inhibiteurs de l'enzyme 5 alpha-reductase
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
BR0110902A (pt) Inibidores de mmp-9/mmp-2
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60106850D1 (de) Wälzschleifen von nichtmetallischen Zahnrädern
BR0316544A (pt) Compostos calcilìticos
NO20005548L (no) Mykobakterieinhibitorer
ITMI20011633A0 (it) Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv
BR9809365A (pt) Leptina como um inibidor de proliferação de célula de tumor
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
IT1308656B1 (it) Strumentario per l'applicazione di chiodi endomidollari per fratturemetadiafisiarie e diafisiarie del femore e della tibia.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ARES TRADING S.A. (CH)

B25G Requested change of headquarter approved

Owner name: ARES TRADING S.A. (CH)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020040005826 DE 28/10/2004

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/07/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 17/07/2020